NCT07301034: A Research Study to Look at the Effect of Ziltivekimab on Plaque in the Blood Vessels of the Heart, Compared to Placebo, in People With a Heart Attack
- State
- Under way
- Phase
- Phase 3
- People
- 332 planned
- Started
- 18 Dec 2025
- Primary completion
- 14 Nov 2028
- Arms
- Ziltivekimab dose level 1 + standard of care (SOC)
- Results
- None posted
- 18 Dec 2025: Trial started
- 24 Dec 2025: Trial registered